Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 0.45 Delayed Data As of Dec 05 |  -0.0339 / -6.99%Today’s Change | 0.29 Today|||52-Week Range 3.76 | -85.67% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Biogen Inc |  Sale | 9/26/2023 | 6,000,000 | $0.50 | $3.0M | -33.38% |
Macrae Alexander D | Sale | 2/25/2023 | 54,767 | $2.66 | $145.7K | -84.77% |
Ramelmeier R Andrew /sangamo/ EVP-Technical Operations | Sale | 2/25/2023 | 15,618 | $2.66 | $41.5K | -84.77% |
Dubois Stringfellow Nathalie Senior Vice President & Chief Development Officer | Sale | 2/25/2023 | 9,834 | $2.66 | $26.2K | -84.77% |
Mcclung Mark D Chief Operating Officer & EVP | Sale | 2/25/2023 | 9,745 | $2.66 | $25.9K | -84.77% |
Durabaibu Prathyusha Chief Financial Officer & Senior Vice President | Sale | 2/25/2023 | 7,030 | $2.66 | $18.7K | -84.77% |
Fontenot Jason D Senior Vice President & Chief Scientific Officer | Sale | 2/25/2023 | 6,559 | $2.66 | $17.4K | -84.77% |
Macrae Alexander D | Sale | 5/25/2023 | 10,411 | $1.33 | $13.8K | -66.10% |
Mcclung Mark D Chief Operating Officer & EVP | Sale | 6/25/2023 | 11,528 | $1.19 | $13.7K | -61.79% |
Willoughby Scott B General Counsel & Senior Vice President | Sale | 2/25/2023 | 5,128 | $2.66 | $13.6K | -84.77% |
Page of 5